Free Trial
OTCMKTS:OTLC

Oncotelic Therapeutics (OTLC) Stock Price, News & Analysis

Oncotelic Therapeutics logo
$0.05 +0.01 (+13.73%)
As of 03:03 PM Eastern

About Oncotelic Therapeutics Stock (OTCMKTS:OTLC)

Key Stats

Today's Range
$0.05
$0.05
50-Day Range
$0.04
$0.06
52-Week Range
$0.02
$0.07
Volume
9,540 shs
Average Volume
89,219 shs
Market Capitalization
$23.20 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Oncotelic Therapeutics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
3rd Percentile Overall Score

OTLC MarketRank™: 

Oncotelic Therapeutics scored higher than 3% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Oncotelic Therapeutics.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Oncotelic Therapeutics is -5.30, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Oncotelic Therapeutics is -5.30, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Oncotelic Therapeutics has a P/B Ratio of 2.65. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    0.03% of the float of Oncotelic Therapeutics has been sold short.
  • Short Interest Ratio / Days to Cover

    Oncotelic Therapeutics has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Oncotelic Therapeutics has recently increased by 2,583.87%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Oncotelic Therapeutics does not currently pay a dividend.

  • Dividend Growth

    Oncotelic Therapeutics does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.03% of the float of Oncotelic Therapeutics has been sold short.
  • Short Interest Ratio / Days to Cover

    Oncotelic Therapeutics has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Oncotelic Therapeutics has recently increased by 2,583.87%, indicating that investor sentiment is decreasing significantly.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Oncotelic Therapeutics this week, compared to 0 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Oncotelic Therapeutics insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    39.22% of the stock of Oncotelic Therapeutics is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Read more about Oncotelic Therapeutics' insider trading history.
Receive OTLC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oncotelic Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

OTLC Stock News Headlines

An $8 trillion-dollar discovery 17,000 ft underwater
A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materials critical for AI chips, EV batteries, smartphones, and advanced weapons systems. While few people know about these metals, global powers—including the U.S., China, and Russia—are racing to secure them. And one tiny public company, recently backed by the U.S. government, holds mining rights to over 340 million tons… and near-monopoly access to the richest zone.tc pixel
Oncotelic Therapeutics, Inc. (OTLC) - Yahoo Finance
See More Headlines

OTLC Stock Analysis - Frequently Asked Questions

Oncotelic Therapeutics' stock was trading at $0.0350 on January 1st, 2025. Since then, OTLC stock has increased by 51.4% and is now trading at $0.0530.

Oncotelic Therapeutics, Inc. (OTCMKTS:OTLC) issued its quarterly earnings data on Thursday, August, 19th. The company reported ($0.01) earnings per share for the quarter, topping analysts' consensus estimates of ($0.03) by $0.02.

Shares of OTLC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Oncotelic Therapeutics investors own include MariMed (MRMD), First Wave BioPharma (FWBI), DSS (DSS), Cemex (CX), CohBar (CWBR), ContraFect (CFRX) and Avid Bioservices (CDMO).

Company Calendar

Last Earnings
8/19/2021
Today
8/28/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:OTLC
CIK
908259
Employees
20
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.01)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$4.52 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-9.62%
Return on Assets
-2.72%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.01
Quick Ratio
0.01

Sales & Book Value

Annual Sales
$70 thousand
Price / Sales
331.45
Cash Flow
$0.01 per share
Price / Cash Flow
9.06
Book Value
$0.02 per share
Price / Book
2.65

Miscellaneous

Outstanding Shares
437,770,000
Free Float
248,908,000
Market Cap
$23.20 million
Optionable
Not Optionable
Beta
-0.90
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (OTCMKTS:OTLC) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners